Among them, low expression levels of TLX1 and LHX5 predicted poor overall survival rate of GBM patients and low KPS scores; both two genes showed high diagnostic value in distinguishing the recurrent GBM samples from the primary GBM samples. Here, LHX5 is linked to glioblastoma.